Coloma Jason V
Insider CIK 1676170 · CRVS SVP, Chief Business Officer · MAZE Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-10-01 | 2026-10-02 | 31,908 | $27.02 | $862.2K | 191,447 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-10-01 | 2026-10-02 | 2,593 | $27.02 | $70.1K | 15,558 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-09-03 | 2026-09-04 | 11,282 | $26.01 | $293.4K | 27,491 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-09-03 | 2026-09-04 | 129 | $25.77 | $3.3K | 27,362 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-09-03 | 2026-09-04 | 129 | $25.77 | $3.3K | 27,362 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-09-03 | 2026-09-04 | 11,282 | $26.01 | $293.5K | 27,491 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-09-02 | 2026-09-04 | 9,852 | $26.38 | $259.9K | 40,148 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-09-02 | 2026-09-04 | 1,375 | $27.12 | $37.3K | 38,773 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-09-02 | 2026-09-04 | 1,375 | $27.12 | $37.3K | 38,773 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-09-02 | 2026-09-04 | 9,852 | $26.38 | $259.9K | 40,148 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | M Exercise deriv | 2026-09-01 | 2026-09-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-03 | 31,908 | $26.29 | $838.9K | 223,355 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | M Exercise | 2026-09-01 | 2026-09-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-03 | 2,593 | $26.31 | $68.2K | 18,151 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | M Exercise deriv | 2026-09-01 | 2026-09-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | M Exercise | 2026-09-01 | 2026-09-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-03 | 31,908 | $26.29 | $838.8K | 223,355 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-03 | 2,593 | $26.31 | $68.2K | 18,151 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-08-03 | 2026-08-05 | 1,604 | $27.09 | $43.5K | 255,263 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-08-03 | 2026-08-05 | 30,304 | $26.71 | $809.4K | 256,867 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-08-03 | 2026-08-05 | 154 | $27.09 | $4.2K | 20,744 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-08-03 | 2026-08-05 | 2,439 | $26.71 | $65.1K | 20,898 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-08-03 | 2026-08-05 | 1,604 | $27.09 | $43.4K | 255,263 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-08-03 | 2026-08-05 | 30,304 | $26.71 | $809.5K | 256,867 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-08-03 | 2026-08-05 | 154 | $27.09 | $4.2K | 20,744 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-08-03 | 2026-08-05 | 2,439 | $26.71 | $65.2K | 20,898 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-07-01 | 2026-07-02 | 30,311 | $29.95 | $907.8K | 288,768 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-07-01 | 2026-07-02 | 2,593 | $29.98 | $77.7K | 23,337 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-07-01 | 2026-07-02 | 1,597 | $30.44 | $48.6K | 287,171 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-06-23 | 2026-06-24 | 23,865 | $26.05 | $621.7K | 319,079 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-24 | 2,040 | $26.00 | $53.0K | 25,930 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-24 | 1,953 | $26.00 | $50.8K | 342,944 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-06-01 | 2026-06-03 | 553 | $26.24 | $14.5K | 27,970 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-06-01 | 2026-06-03 | 6,090 | $26.20 | $159.6K | 344,897 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-05-26 | 2026-05-27 | 25,582 | $26.02 | $665.6K | 350,987 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-05-22 | 2026-05-27 | 2,478 | $26.00 | $64.4K | 28,523 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-05-22 | 2026-05-27 | 4,504 | $26.00 | $117.1K | 376,569 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-05-15 | 2026-05-18 | 1,822 | $26.00 | $47.4K | 381,073 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | S Sale | 2026-05-15 | 2026-05-18 | 116 | $26.00 | $3.0K | 31,001 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | A Award deriv | 2026-03-02 | 2026-03-03 | 75,000 | — | $0 | 75,000 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | A Award deriv | 2026-03-02 | 2026-03-03 | 150,000 | — | $0 | 150,000 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | A Award deriv | 2025-09-22 | 2025-09-24 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2016-06-08 | 2016-06-10 | 200,000 | — | $0 | 200,000 | SEC↗ |